MiRNA Sequencing and Assay Market to Grow at a CAGR of 11.9% to reach US$ 468.99 Million from 2020 to 2027

1
MiRNA Sequencing and Assay Market 
MiRNA Sequencing and Assay Market Forecast to
2027 - COVID-19 Impact and Global Analysis By
Product (Library Preparation and Consumables),
Technology (Sequencing By Synthesis, Nanopore,
and Ion Semiconductor Sequencing), and End User
(Research Institute, Academia, and CRO) By
Geography
2
Current and future Market Scenario
MiRNA Sequencing and Assay Market 

• According to our new market research study on
  MiRNA Sequencing and Assay Market to 2028
  Global Analysis and Forecast by Type,
  Treatment, and End User, the market is expected
  to reach US 468.99 million by 2027 from US
  192.31 million in 2019 it is estimated to grow
  at a CAGR of 11.9 from 2020 to 2027.
• The growth of the miRNA sequencing and assay
  market is mainly attributed to the widening range
  of miRNA applications and rise in funding for
  genomics research. However, the challenges
  related to delivery, efficacy, and specificity of
  miRNA-based therapeutics may hinder the market
  growth.

3
Market Segments
MiRNA Sequencing and Assay Market   
By Technology Sequencing by Synthesis Nanopore Io
n Semiconductor Sequencing
By Product Library Preparation Consumables
By End User Research Institute Academia CRO
4
Leading Players
MiRNA Sequencing and Assay Market  
Company Profiles in MiRNA Sequencing and Assay
Market are Illumina Inc. Thermo Fisher
Scientific Inc. Qiagen Perkin Elmer Inc. Takara
Bio Inc. New England Biolabs NorgenBiotek
Corp TriLinkBioTechnologies Inc Lexogen
GmbH Oxford Nanopore Technologies
5
MiRNA Sequencing and Assay Market  
Access Full Research Report at
https//www.theinsightpartners.com/reports/MiRNA
Sequencing and Assay-market
Thank You!

• Thank You!